Finsterer J, Scorza FA, Scorza CA, Fiorini AC, et al. Diagnosing SARS-CoV-2 associated Guillain-Barre syndrome requires cerebro-spinal-fluid studies. J Neuroimmunol 2021;357:577609.
PMID: 34023795